Warby Parker WRBY
NYSE WRBY
$27.44 -0.02 (-0.07%)
At close: Aug 21, 2026 · 4:00 PM EDT

Warby Parker (WRBY) Total Non-Current Liabilities (2020 - 2026)

Warby Parker's (WRBY) quarterly Total Non-Current Liabilities came in at $359.0 million in Q1 2026, up 9.67% YoY from $327.4 million in Q1 2025, and up 2.03% on a QoQ basis from $351.9 million in Q4 2025.

Warby Parker (WRBY) Total Non-Current Liabilities (2020 - 2026) Analysis & Trends

Warby Parker (WRBY) has 7 years of Total Non-Current Liabilities data on file, last reported at $359.0 million in Q1 2026.

  • Quarterly Total Non-Current Liabilities rose 9.67% year-over-year to $359.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $359.0 million (up 9.67% YoY) and the FY2025 annual result came in at $351.9 million, up 4.89% from the prior year.
  • Total Non-Current Liabilities rose to $359.0 million in Q1 2026, from $351.9 million in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $359.0 million in Q1 2026 to a low of $258.2 million in Q2 2023.
  • A 5-year average of $296.6 million and a median of $280.4 million in 2022 frame the typical range for Total Non-Current Liabilities.
  • Annual changes were most pronounced in 2022 — Total Non-Current Liabilities soared 81.31% — and 2023, when it slipped 1.12%.
  • Tracing WRBY's Total Non-Current Liabilities over 5 years: stood at $280.4 million in 2022, then decreased by 1.12% to $277.3 million in 2023, then rose by 21.0% to $335.5 million in 2024, then rose by 4.89% to $351.9 million in 2025, then advanced by 2.03% to $359.0 million in 2026.
  • The last three Total Non-Current Liabilities figures came in at $359.0 million (Q1 2026), $351.9 million (Q4 2025), and $336.0 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Intuitive Surgical 134.13 Bn 128.91 Bn 1.96 Bn 1.92 Bn
2 Becton Dickinson 52.76 Bn 51.90 Bn 2.32 Bn 48.34 Bn
3 Alcon 35.81 Bn 34.46 Bn 1.68 Bn 6.34 Bn
4 Resmed 33.72 Bn 32.25 Bn 861.22 Mn 985.45 Mn
5 Medline 29.38 Bn 26.70 Bn 2.22 Bn 17.56 Bn
6 West Pharmaceutical Services 25.00 Bn 24.57 Bn 329.20 Mn 996.30 Mn
7 Solventum 15.46 Bn 15.06 Bn 1.29 Bn 8.96 Bn
8 Cooper Companies 14.88 Bn 14.74 Bn 735.40 Mn 3.98 Bn
9 Baxter International 13.58 Bn 11.43 Bn 1.03 Bn 12.41 Bn
10 Warby Parker 3.41 Bn 3.12 Bn 136.46 Mn 378.92 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 378.92 Mn
Mar 31, 2026 359.03 Mn
Dec 31, 2025 351.88 Mn
Sep 30, 2025 335.95 Mn
Jun 30, 2025 339.28 Mn
Mar 31, 2025 327.39 Mn
Dec 31, 2024 335.47 Mn
Sep 30, 2024 300.22 Mn
Jun 30, 2024 287.72 Mn
Mar 31, 2024 275.53 Mn
Dec 31, 2023 277.26 Mn
Sep 30, 2023 268.91 Mn
Jun 30, 2023 258.18 Mn
Mar 31, 2023 259.96 Mn
Dec 31, 2022 280.39 Mn
Sep 30, 2022 264.37 Mn
Jun 30, 2022 259.60 Mn
Mar 31, 2022 261.57 Mn
Dec 31, 2021 154.65 Mn
Sep 30, 2021 165.33 Mn